Team Leader
Team Staff
Dr. Diana Julie Leeming
Dr. Mette Juul Fisker Nielsen
Institute Presentation
Nordic Bioscience is dedicated to preclinical and clinical drug development, which specializes in precision medicine using biomarkers, developed using Protein Fingerprint™ technology. A given target, protein, or metabolite, which is cleaved by a specific enzyme yields neo-epitopes that are targeted by specific monoclonal antibodies.
We will use this technology to design, develop, and validate biomarker assays that can be used as companion biomarker tools to identify the patients most likely to respond to treatment. In DECISION, we will design a prognostic test and a test for response to combinatorial therapy in WP4 to be used in WP5. Nordic Bioscience will also support the exploitation, valorization, and sustainability of new intellectual property (IP) in WP7.